<unk>  is a combination of an anticholinergic and a long-acting beta2-adrenergic agonist that is FDA approved for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include urinary tract infection and cough.
Glycopyrrolate and formoterol fumarate
Tiotropium bromide and olodaterol
Lumacaftor and ivacaftor
Fluticasone/salmeterol
Ipratropium Bromide And Albuterol
Budesonide And Formoterol Fumarate Dihydrate
Indacaterol and glycopyrrolate
Netupitant and palonosetron